LMAT stock forecast
Our latest prediction for Lemaitre Vascular Inc's stock price was made on the May 13, 2021 when the stock price was at 48.64$.
In the short term (2weeks), LMAT's stock price should underperform the market by -1.20%. During that period the price should oscillate between -5.56% and +4.85%.
In the medium term (3months), LMAT's stock price should underperform the market by -1.56%. During that period the price should oscillate between -16.39% and +13.44%.Get email alerts
Create a solid portfolio with LMAT
About Lemaitre Vascular Inc
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.
At the moment the company generates 135M USD in revenues.
On its last earning announcement, the company reported a profit of 1.15$ per share.
The book value per share is 6.20$
Three months stock forecastMay 13, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|